GlassScriptPhysician profile
Chloe Mulligan
NPI 1477297067
$4,270.26
in general payments reported to CMS, 2019-2025
17 companies · $2,765 in 2025
The $2,765 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $429 · 2023: $522 · 2024: $554 · 2025: $2,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,279 · Travel and Lodging: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.57 |
| Travel and Lodging | $1,562.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,257.70 | 2025 | Ortholoc 2 Lapifuse, Valor, Ortholoc 3di |
| Alaska Medical Technologies, LLC | $699.75 | 2025 | |
| Smith+Nephew, INC. | $477.84 | 2022-2025 | Stravix, Grafix, Oasis |
| Depuy Synthes Sales INC. | $305.87 | 2023-2025 | Motoband, Na |
| Treace Medical Concepts, INC. | $275.22 | 2023-2024 | |
| Axogen | $193.22 | 2023 | Avance Nerve Graft |
| Mimedx Group, INC. | $145.73 | 2025 | |
| Avita Medical Americas, LLC | $144.65 | 2025 | Cohealyx, Recell, Permeaderm |
| Sanara Medtech INC. | $122.81 | 2024 | Celleraterx |
| Orthofix Medical, INC. | $113.21 | 2025 | Physio-Stim |
| Davol INC. | $102.22 | 2022 | |
| Integra Lifesciences Corporation | $98.02 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Flower Orthopedics Coporation | $93.04 | 2022-2023 | |
| Polynovo North America LLC | $85.00 | 2025 | Novosorb Btm |
| Bioventus LLC | $73.49 | 2022-2025 | Exogen Ultrasound Bone Healing System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $65.55 | 2025 | Stimulan |
| Novo Nordisk INC | $16.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Mulligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.